Holly Kemberling

16.7k total citations · 1 hit paper
9 papers, 567 citations indexed

About

Holly Kemberling is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Holly Kemberling has authored 9 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Holly Kemberling's work include Genetic factors in colorectal cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Colorectal Cancer Treatments and Studies (2 papers). Holly Kemberling is often cited by papers focused on Genetic factors in colorectal cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Colorectal Cancer Treatments and Studies (2 papers). Holly Kemberling collaborates with scholars based in United States. Holly Kemberling's co-authors include Dung T. Le, Luis A. Díaz, Todd S. Crocenzi, James J. Lee, Bert Vogelstein, Hao Wang, George A. Fisher, Jennifer N. Uram, Minori Koshiji and Bjarne R. Bartlett and has published in prestigious journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer and Biology of Blood and Marrow Transplantation.

In The Last Decade

Holly Kemberling

9 papers receiving 557 citations

Hit Papers

PD-1 blockade in tumors with mismatch repair deficiency. 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PD-1 blockade in tumors with mismatch repair deficiency.
    2015 339 citations Dung T. Le, Jennifer N. Uram et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holly Kemberling United States 7 471 185 154 125 118 9 567
Takashi Ichimura Japan 12 361 0.8× 87 0.5× 274 1.8× 143 1.1× 108 0.9× 52 579
Florian Huemer Austria 13 323 0.7× 79 0.4× 133 0.9× 55 0.4× 76 0.6× 46 502
Ellie Corigliano United States 3 546 1.2× 65 0.4× 307 2.0× 146 1.2× 80 0.7× 4 635
Ashish Sangal United States 8 339 0.7× 58 0.3× 208 1.4× 60 0.5× 132 1.1× 19 464
Cyril Abdeddaim France 10 302 0.6× 131 0.7× 92 0.6× 86 0.7× 88 0.7× 30 519
Debra Hanks United States 5 404 0.9× 58 0.3× 206 1.3× 155 1.2× 65 0.6× 10 510
Hitomi Tamura Japan 6 553 1.2× 188 1.0× 199 1.3× 145 1.2× 73 0.6× 11 661
Estrella M. Carballido United States 12 264 0.6× 78 0.4× 175 1.1× 185 1.5× 79 0.7× 27 499
Hanguang Hu China 15 348 0.7× 112 0.6× 114 0.7× 108 0.9× 98 0.8× 47 533
Nami Hirano Japan 7 535 1.1× 178 1.0× 191 1.2× 134 1.1× 70 0.6× 15 644

Countries citing papers authored by Holly Kemberling

Since Specialization
Citations

This map shows the geographic impact of Holly Kemberling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Kemberling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Kemberling more than expected).

Fields of papers citing papers by Holly Kemberling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Kemberling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Kemberling. The network helps show where Holly Kemberling may publish in the future.

Co-authorship network of co-authors of Holly Kemberling

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Kemberling. A scholar is included among the top collaborators of Holly Kemberling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Kemberling. Holly Kemberling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kelly, Ronan J., Katherine M. Bever, Joseph Chao, et al.. (2023). Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer. Journal for ImmunoTherapy of Cancer. 11(6). e006658–e006658. 14 indexed citations
2.
Cheung, Laurene S., Ling‐Ling Chen, Thomas Schaffer, et al.. (2021). Anti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signatures. Journal for ImmunoTherapy of Cancer. 9(6). e002345–e002345. 9 indexed citations
3.
Le, Dung T., Jennifer N. Uram, Hao Wang, et al.. (2016). Programmed death-1 blockade in mismatch repair deficient colorectal cancer.. Journal of Clinical Oncology. 34(15_suppl). 103–103. 85 indexed citations
4.
Díaz, Luis A., Jennifer N. Uram, Hao Wang, et al.. (2016). Programmed death-1 blockade in mismatch repair deficient cancer independent of tumor histology.. Journal of Clinical Oncology. 34(15_suppl). 3003–3003. 27 indexed citations
5.
Le, Dung T., Jennifer N. Uram, Hao Wang, et al.. (2016). PD-1 blockade in mismatch repair deficient non-colorectal gastrointestinal cancers.. Journal of Clinical Oncology. 34(4_suppl). 195–195. 49 indexed citations
6.
Le, Dung T., Jennifer N. Uram, Hao Wang, et al.. (2015). PD-1 blockade in tumors with mismatch repair deficiency.. Journal of Clinical Oncology. 33(15_suppl). LBA100–LBA100. 339 indexed citations breakdown →
7.
Le, Dung T., Jennifer N. Uram, Hao Wang, et al.. (2015). PD-1 blockade in tumors with mismatch repair deficiency.. Journal of Clinical Oncology. 33(18_suppl). LBA100–LBA100. 38 indexed citations
8.
Le, Dung T., Nilofer S. Azad, Dan Laheru, et al.. (2014). Phase 2 study of programmed death-1 antibody (anti-PD-1, MK-3475) in patients with microsatellite unstable (MSI) tumors.. Journal of Clinical Oncology. 32(15_suppl). TPS3128–TPS3128. 4 indexed citations
9.
Bolaños‐Meade, Javier, Holly Kemberling, Christopher Gamper, et al.. (2011). Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation (haplo-BMT) With Post-Transplant High-Dose Cyclophosphamide (Cy) in Patients With Severe Hemoglobinopathies. Biology of Blood and Marrow Transplantation. 17(2). S285–S285. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takashi Ichimura Breakdown of academic impact, for papers by Florian Huemer Breakdown of academic impact, for papers by Ellie Corigliano Breakdown of academic impact, for papers by Ashish Sangal Breakdown of academic impact, for papers by Cyril Abdeddaim Breakdown of academic impact, for papers by Debra Hanks Breakdown of academic impact, for papers by Hitomi Tamura Breakdown of academic impact, for papers by Estrella M. Carballido Breakdown of academic impact, for papers by Hanguang Hu Breakdown of academic impact, for papers by Nami Hirano
Rankless by CCL
2026